[Efficacy of the conservative treatment of patients with inoperable esophageal cancer].
The results of gamma-beam therapy of esophageal cancer leave much to be desired. However betatron therapy improves them. To compare the results of esophageal cancer therapy 4 therapeutic modalities were employed: the 1st group--chemoradiotherapy (methotrexate at a weekly dose of 45 mg), the 2nd group--chemoradiotherapy (methotrexate at a dose of 10 mg alternating with prospidin at a dose of 200 mg), the 3rd group--radiotherapy (inhibitory radiation), the 4th group--radiotherapy (gamma-beam therapy). Higher efficacy of chemoradiotherapy as compared to radiotherapy only was established.
Azhigaliev
N A
NA
Sadykov
S S
SS
Kusherbaev
S K
SK
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D011379:Prognosis; D011447:Prospidium / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011447:Prospidium; D008727:Methotrexate
Effektivnost' konservativnogo lecheniia neoperabel'nykh bol'nykh rakom pishchevoda.